Literature DB >> 21303743

Microbiological evaluation of commercial probiotic products available in the USA in 2009.

L Drago1, V Rodighiero, T Celeste, L Rovetto, E De Vecchi.   

Abstract

Probiotics are widely used to prevent and treat several diseases. Many commercial products are available worldwide. However, there is no clear international or local legislation about them and previous studies showed that most of the tested products are not in conformity with international guidelines. The aim of this study was to determine if products available in the USA market in 2009 were correctly labeled in terms of quantity of viable bacteria, identification of species and cross contamination by species not on the label. Disturbingly, we found that only 4 of 13 products (31%) were in accordance with label claims. Our results suggest the need for adequate control of probiotic production as well as periodical screenings by competent organizations to monitor the effect of storage on product quality.

Mesh:

Year:  2010        PMID: 21303743     DOI: 10.1179/joc.2010.22.6.373

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  14 in total

1.  Survey and evidence based review of probiotics used in very low birth weight preterm infants within the United States.

Authors:  S Viswanathan; C Lau; H Akbari; C Hoyen; M C Walsh
Journal:  J Perinatol       Date:  2016-09-01       Impact factor: 2.521

Review 2.  Status of microbial based cleaning products in statutory regulations and ecolabelling in Europe, the USA, and Canada.

Authors:  Armin Spök; George Arvanitakis; Gwendolyn McClung
Journal:  Food Chem Toxicol       Date:  2017-12-29       Impact factor: 6.023

Review 3.  Evidence-based guidelines for use of probiotics in preterm neonates.

Authors:  Girish C Deshpande; Shripada C Rao; Anthony D Keil; Sanjay K Patole
Journal:  BMC Med       Date:  2011-08-02       Impact factor: 8.775

4.  Enumeration of Probiotic Strain Lacticaseibacillus rhamnosus GG (ATCC 53103) Using Viability Real-time PCR.

Authors:  Hanan R Shehata; Steven G Newmaster
Journal:  Probiotics Antimicrob Proteins       Date:  2021-09-30       Impact factor: 4.609

Review 5.  Antiviral Effects and Underlying Mechanisms of Probiotics as Promising Antivirals.

Authors:  Yanjin Wang; Assad Moon; Jingshan Huang; Yuan Sun; Hua-Ji Qiu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-06       Impact factor: 6.073

6.  Culture-Independent Metagenomic Surveillance of Commercially Available Probiotics with High-Throughput Next-Generation Sequencing.

Authors:  Jennifer N Patro; Padmini Ramachandran; Tammy Barnaba; Mark K Mammel; Jada L Lewis; Christopher A Elkins
Journal:  mSphere       Date:  2016-03-30       Impact factor: 4.389

Review 7.  Bacillus As Potential Probiotics: Status, Concerns, and Future Perspectives.

Authors:  Fouad M F Elshaghabee; Namita Rokana; Rohini D Gulhane; Chetan Sharma; Harsh Panwar
Journal:  Front Microbiol       Date:  2017-08-10       Impact factor: 5.640

Review 8.  Pregnancy outcomes in women taking probiotics or prebiotics: a systematic review and meta-analysis.

Authors:  Alexander Jarde; Anne-Mary Lewis-Mikhael; Paul Moayyedi; Jennifer C Stearns; Stephen M Collins; Joseph Beyene; Sarah D McDonald
Journal:  BMC Pregnancy Childbirth       Date:  2018-01-08       Impact factor: 3.007

9.  Microbiological Assessment of the Quality of Some Commercial Products Marketed as Lactobacillus crispatus-Containing Probiotic Dietary Supplements.

Authors:  Francesco Di Pierro; Valeria Polzonetti; Vania Patrone; Lorenzo Morelli
Journal:  Microorganisms       Date:  2019-11-03

10.  Synergistic protection of combined probiotic conditioned media against neonatal necrotizing enterocolitis-like intestinal injury.

Authors:  Sheng-Ru Shiou; Yueyue Yu; Yuee Guo; Shu-Mei He; C Haikaeli Mziray-Andrew; Jeanette Hoenig; Jun Sun; Elaine O Petrof; Erika C Claud
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.